Welcure Drugs & Pharmaceuticals Ltd.
Snapshot View

7.86 +0.37 ▲4.9%

02 August 2021, 04:00:00 P.M.
Volume: 6,778

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website
Financial Indicators
Market Cap 10.62 Cr.
Earnings per share (EPS) 0.02 Trailing Twelve Months Ending 2021-06
Price-Earning Ratio (PE) 408.48 Trailing Twelve Months Ending 2021-06
Industry PE 118.44 Trailing Twelve Months Ending 2021-06
Book Value / Share 1.06 Trailing Twelve Months Ending 2021-06
Price to Book Value 7.38 Calculated using Price: 7.86
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.35 Cr. 13,512,100 Shares
FaceValue 10
Company Profile

Welcure Drugs & Pharmaceuticals Ltd. (WDPL)  was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992.

Welcure is an Internationally ISO 9001:2000 and WHO-GMP Certified Company. It has to its credit the most modern and sophisticated manufacturing facilities of International Standards which include ultramodern plant, machinery and equipment, own R & D, in house testing laboratory and captive power generation.

Presently, the Company is engaged in the business of manufacture and marketing of pharmaceuticals formulations in the form of tablets, capsules and dry syrups.  The Company is manufacturing over hundred varieties of formulations including antibiotics, sulpha drugs, vitamins, analgesics, antipyretics, corticosteroids, anti-malarials, anti-dysentery, anti-tuberculosis, anti-diabetics, tranquilisers, sedatives and gastro intestinals.  The products of the company have already been well accepted in the domestic markets and the Company has an established customer base.

In March 2000 WDPL entered into a five-year agreement with Bihar Drugs and Chemicals Ltd (BDCL), a subsidiary of Bihar State Pharmaceutical and Chemical Development Corporation Ltd, for manufacturing various pharmaceutical pro ducts (both generic as well as branded) for the latter on loan licence basis. WDPL manufactures the drugs in tablet, capsule and syrup form at its facilities situated in Bhiwadi (Rajasthan).

The Company’s principal activity is to manufacture pharmaceutical products. The products of the Company include tablets, capsules, liquid orals and dry syrups.

Product range of the company includes:

Welcure manufactures a large variety of pharmaceutical formulations, covering almost all ailments, about 250 in numbers. Some of our known products include:

  • Brucure
  • Diclo-plus, Dimcinplus
  • Nimesulide
  • Nimagyltd (tongue dissolvent)
  • Ibucure & Relaxon Forte
  • Coldrest, Alert10004 Coldhistex
  • Cezen & Cezen Forte, Cezen CD
  • Kuffwel
  • X-Dryl, X-Dryl Forte
  • Renact DM
  • Renact DC
  • Diaroban
  • Welcee (Chewable Tab.)
  • Calbiplex
  • Wormicide
  • X-Clox
  • Weloxy-L
  • Welquin
  • Nortin, Cipcin-TNZ
  • Sarvo
  • B-Rest
  • Lopcure
  • Rifampicin, Ethambutol, Rifa-Z
  • Weloxy-P,Amicure-P
  • Norkid

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+4.94%
1 Week
+27.18%
1 Month
+162.00%
3 Month
+274.29%
6 Month
+260.55%
1 Year
+577.59%
2 Year
+1472.00%
5 Year
+359.65%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 108.61 -65.80 17.83 -49.46 131.66
Return on Capital Employed (%) 108.91 -65.46 18.22 -48.94 131.90
Return on Assets (%) 29.03 5.68 10.40 227.41 94.50 -58.62 14.57 -34.54 112.91

Balance Sheet View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 0 0 0 0 0 0 0 0 0
Non Curr. Liab.
Curr. Liab. 0 0 0 0 0
Minority Int.
Equity & Liab. 0 0 0 0 0 0 0 0 0
Non Curr. Assets
Curr. Assets 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 0 0 0 0 0 0 0

Profit Loss View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 0 0 0 0 0 0 0 0 0
Other Income 0 0 0
Total Income 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0
Interest
Depreciation
Taxation
Exceptional Items
PAT 0 0 0 0 0 0 0

Cash Flow View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 0
Cash Fr. Finan.
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 14.12 14.12 14.12 14.12 14.12 14.12 14.12 14.12 14.12
Public 85.88 85.88 85.88 85.88 85.88 85.88 85.88 85.88 85.88
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 13 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated 12th July 2021 regarding approval of Un-audited Financial Results for Quarter ended 30th June 2021; please find enclosed the newspaper advertisement published in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 in Financial Express (English) and Jansatta (Hindi) on 13th July 2021.

This is for your information and records.
Tue, 13 Jul 2021
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In continuation of our letter dated 12th July 2021 regarding proceeding of 29th Annual General Meeting (AGM) of Welcure Drugs & Pharmaceuticals Ltd (the Company) held on Monday 12th July 2021 at 10:00 A.M. through Video Conferencing/other audio visual means please find enclosed herewith the voting results (for E-Voting) along with the Scrutinizers Report as per the provision of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

This is for your information and records.
Tue, 13 Jul 2021
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Welcure Drugs & Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here

Technical Scans View Details

Mon, 02 Aug 2021
Close Crossing Last Week High Close Crossing Last Week High
Close Crossing Last Month High Close Crossing Last Month High
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Crossing 52 Week High Close Crossing 52 Week High
Opening at High Opening at High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 158,070.20 1,437.25 +1.2%
Adani Transmission Ltd. 99,439.33 904.15 +0.0%
Sundram Fasteners Ltd. 16,382.66 779.65 +2.1%
Redington (India) Ltd. 12,916.43 330.70 +1.0%
MMTC Ltd. 7,425.00 49.50 -1.9%
Novartis India Ltd. 2,402.41 975.25 +1.7%
MSTC Ltd. 1,990.91 282.80 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 171.32 1,437.25 +1.2%
Adani Transmission Ltd. Consolidated 2021-03 81.24 904.15 +0.0%
Sundram Fasteners Ltd. Consolidated 2021-03 45.61 779.65 +2.1%
Redington (India) Ltd. Consolidated 2021-03 17.08 330.70 +1.0%
MMTC Ltd. Standalone 2020-12 0.00 49.50 -1.9%
Novartis India Ltd. Standalone 2021-03 114.95 975.25 +1.7%
MSTC Ltd. Consolidated 2021-03 17.63 282.80 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 9.21 1,437.25 +1.2%
Adani Transmission Ltd. Consolidated 2021-03 16.33 904.15 +0.0%
Sundram Fasteners Ltd. Consolidated 2021-03 6.98 779.65 +2.1%
Redington (India) Ltd. Consolidated 2021-03 2.62 330.70 +1.0%
MMTC Ltd. Standalone 2020-12 7.35 49.50 -1.9%
Novartis India Ltd. Standalone 2021-03 3.36 975.25 +1.7%
MSTC Ltd. Consolidated 2021-03 3.57 282.80 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 1,437.25 +1.2%
Adani Transmission Ltd. Consolidated 2021-03 4.89 904.15 +0.0%
Sundram Fasteners Ltd. Consolidated 2021-03 0.29 779.65 +2.1%
Redington (India) Ltd. Consolidated 2021-03 0.09 330.70 +1.0%
MMTC Ltd. Standalone 2020-03 4.23 49.50 -1.9%
Novartis India Ltd. Standalone 2021-03 0.00 975.25 +1.7%
MSTC Ltd. Consolidated 2020-03 0.55 282.80 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 1,437.25 +1.2%
Adani Transmission Ltd. Consolidated 2021-03 22.81 904.15 +0.0%
Sundram Fasteners Ltd. Consolidated 2021-03 16.70 779.65 +2.1%
Redington (India) Ltd. Consolidated 2021-03 17.02 330.70 +1.0%
MMTC Ltd. Standalone 2020-03 -20.23 49.50 -1.9%
Novartis India Ltd. Standalone 2021-03 2.91 975.25 +1.7%
MSTC Ltd. Consolidated 2020-03 23.14 282.80 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 7.88 1,437.25 +1.2%
Adani Transmission Ltd. Consolidated 2021-03 10.89 904.15 +0.0%
Sundram Fasteners Ltd. Consolidated 2021-03 17.31 779.65 +2.1%
Redington (India) Ltd. Consolidated 2021-03 21.81 330.70 +1.0%
MMTC Ltd. Standalone 2020-03 -2.16 49.50 -1.9%
Novartis India Ltd. Standalone 2021-03 6.67 975.25 +1.7%
MSTC Ltd. Consolidated 2020-03 22.93 282.80 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 1,437.25 +1.2%
Adani Transmission Ltd. Consolidated 2021-03 9,926.33 904.15 +0.0%
Sundram Fasteners Ltd. Consolidated 2021-03 3,644.29 779.65 +2.1%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 330.70 +1.0%
MMTC Ltd. Standalone 2020-03 26,304.71 49.50 -1.9%
Novartis India Ltd. Standalone 2021-03 381.35 975.25 +1.7%
MSTC Ltd. Consolidated 2020-03 1,231.40 282.80 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 1,437.25 +1.2%
Adani Transmission Ltd. Consolidated 2021-03 1,289.57 904.15 +0.0%
Sundram Fasteners Ltd. Consolidated 2021-03 362.71 779.65 +2.1%
Redington (India) Ltd. Consolidated 2021-03 786.61 330.70 +1.0%
MMTC Ltd. Standalone 2020-03 -220.48 49.50 -1.9%
Novartis India Ltd. Standalone 2021-03 20.90 975.25 +1.7%
MSTC Ltd. Consolidated 2020-03 99.71 282.80 -0.4%